Lyell Immunopharma, Inc. (LYEL) Net earnings per share growth forecast for next year

Symbol and logo of brand Lyell Immunopharma Inc (LYEL)

Lyell Immunopharma generates revenue through partnerships and future royalties from T-cell therapies for the treatment of solid tumors. The net income per share growth target for the coming year illustrates the sensitivity of forecasts to market changes, and this parameter has settled at 3.40. The company's pricing power is based on immune cell rejuvenation technologies, while its strategy relies on large-scale international trials of CAR-T products.

LYEL - Lyell Immunopharma Inc Earnings growth forecast for next year over the range 07/04/2022 - 11/18/2026

Metric breakdowns and analytics for Lyell Immunopharma Inc (LYEL)

- price and consensus price forecast:
Analysis of all company metrics:Lyell Immunopharma Inc
Core merchandise of Lyell

Lyell Immunopharma's proprietary T-cell product manufacturing facility reduces production costs, strengthening its fundamental resilience. The earnings per share (EPS) revision history visualizes the consolidated analyst forecast regarding EPS growth rates for the coming year. This trajectory allows investors to filter out market noise, capturing the real dynamics of the business's future profitability. The indicator serves as an objective tool for assessing the asset's investment attractiveness.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|IPHA - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year PYXS (Pyxis Oncology, Inc.)|Projected earnings per share increase next year CGEN|Earnings growth forecast for next year IOBT (IO Biotech)|Expected earnings per share trend next year STRO|minktherapeutics.com - Earnings growth forecast for next year|Expected net earnings per share growth next year Werewolf Therapeutics, Inc.|Immix (IMMX) - Net earnings per share growth forecast for next year|ALX Oncology Holdings - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Cue Biopharma|Earnings growth forecast for next year pdsbiotech.com|Net earnings per share growth forecast for next year sonnetbio.com (SONN)|MAIA: Net earnings per share change forecast for next year|Liminatus Pharma Inc. - Expected earnings per share growth for next year|LAVA Therapeutics N.V. (LVTX) - Expected net earnings per share growth next year|NXTC - Net earnings per share growth forecast for next year|LPTX: Net earnings per share growth forecast for next year|Intensity Therapeutics (INTS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Sensei Bio (SNSE)|TOVX (Theriva Biologics Inc) - Earnings growth forecast for next year|Gritstone bio (GRTS) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year KA|Consensus forecast of earnings per share growth for next year NexImmune Inc|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year